With reference to its letter dated February 5, 2024, informing about disposal of business assets of Eugia US Manufacturing LLC, a wholly owned step- down subsidiary of the Company. In this regard, Aurobindo Pharma has informed that the aforementioned disposal of business assets has been completed on May 1, 2024.
The above information is a part of company’s filings submitted to BSE.